Uwe Wolfrum, Joshua Linnert, Baran E Güler, Joshua Klein, Jacques S Fritze, Nicole Wenck, Kerstin Nagel-Wolfrum
{"title":"Identification of Unexpected Pathomechanisms Underlying the Human Usher Syndrome.","authors":"Uwe Wolfrum, Joshua Linnert, Baran E Güler, Joshua Klein, Jacques S Fritze, Nicole Wenck, Kerstin Nagel-Wolfrum","doi":"10.1007/978-3-031-76550-6_28","DOIUrl":null,"url":null,"abstract":"<p><p>Human Usher syndrome (USH) is the most common form of hereditary deaf-blindness, characterized by inner ear defects and late-onset vision loss. USH is a complex genetic disorder, clinically and genetically heterogeneous. To date, there is no treatment for the ocular phenotype of any USH subtype, as the underlying pathomechanisms of the disease in the eye are far from being understood. We aim to elucidate the function of USH proteins to gain insight into the pathomechanisms leading to the retinal phenotype in USH. Here, we focus on the USH1 proteins SANS (USH1G) and harmonin (USH1C), and the USH2C protein ADGRV1. Results from affinity capture approaches revealed putative interacting proteins to these USH proteins, indicative of diverse various unexpected molecular pathways and modules. Functional studies in both cellular and animal models confirmed the roles of SANS in the pre-mRNA splicing of other retinal genes, especially USH genes and harmonin as a suppressor of the canonical Wnt signaling. Additionally, ADGRV1 showed characteristics of a metabotropic mechanoreceptor regulating cell adhesions, Ca<sup>2+</sup> homeostasis of the cell, and autophagy. The dysfunction of these pathways and processes may contribute to the development of USH and are novel potential targets for future therapies.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1468 ","pages":"171-175"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in experimental medicine and biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/978-3-031-76550-6_28","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0
Abstract
Human Usher syndrome (USH) is the most common form of hereditary deaf-blindness, characterized by inner ear defects and late-onset vision loss. USH is a complex genetic disorder, clinically and genetically heterogeneous. To date, there is no treatment for the ocular phenotype of any USH subtype, as the underlying pathomechanisms of the disease in the eye are far from being understood. We aim to elucidate the function of USH proteins to gain insight into the pathomechanisms leading to the retinal phenotype in USH. Here, we focus on the USH1 proteins SANS (USH1G) and harmonin (USH1C), and the USH2C protein ADGRV1. Results from affinity capture approaches revealed putative interacting proteins to these USH proteins, indicative of diverse various unexpected molecular pathways and modules. Functional studies in both cellular and animal models confirmed the roles of SANS in the pre-mRNA splicing of other retinal genes, especially USH genes and harmonin as a suppressor of the canonical Wnt signaling. Additionally, ADGRV1 showed characteristics of a metabotropic mechanoreceptor regulating cell adhesions, Ca2+ homeostasis of the cell, and autophagy. The dysfunction of these pathways and processes may contribute to the development of USH and are novel potential targets for future therapies.
期刊介绍:
Advances in Experimental Medicine and Biology provides a platform for scientific contributions in the main disciplines of the biomedicine and the life sciences. This series publishes thematic volumes on contemporary research in the areas of microbiology, immunology, neurosciences, biochemistry, biomedical engineering, genetics, physiology, and cancer research. Covering emerging topics and techniques in basic and clinical science, it brings together clinicians and researchers from various fields.